High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines

Clinical Microbiology and Infection

Volumn 20, Issue 7, 2014, Pages 684-689

  del Amo, E ^a   Brotons, P ^a   Monsonis, M ^a   Trivino M ^a   Inigo M ^a   Selva, L ^a   Sa Leao R ^b   Munoz Almagro C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

Author keywords

Carriage; Conjugate vaccines; Pneumococcal disease; Serotypes; Streptococcus pneumoniae

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; TETRACYCLINE; 13-VALENT PNEUMOCOCCAL VACCINE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; HUMAN; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PEDIATRICS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; SEROTYPING; VACCINATION; BODY FLUID; CHILD; CLASSIFICATION; FEMALE; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; NASOPHARYNX; PATHOGENICITY; PATHOLOGY; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; SPAIN; STREPTOCOCCUS PNEUMONIAE; VIRULENCE;

STREPTOCOCCUS PNEUMONIAE;

BODY FLUIDS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROGROUP; SPAIN; STREPTOCOCCUS PNEUMONIAE; VIRULENCE;

EID: 84905057704     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12422     Document Type: Article

References (33)

1. WHO. New and Under-utilized Vaccines Implementation (NUVI) - WHO position paper on pneumococcus. Wkly Epidemiol Rec 2003; 78: 97-120.
2. Sa-Leao R, Nunes S, Brito-Avo A et al. High rates of transmission of and colonization by Streptococcus pneumoniae and Haemophilus influenzae within a day care center revealed in a longitudinal study. J Clin Microbiol 2008; 46: 225-234.
3. Calix JJ, Porambo RJ, Brady AM et al. Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae serotype 20 strains: discovery of a new pneumococcal serotype. J Biol Chem 2012; 287: 27885-27894.
4. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000; 30: 100-121.
5. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003; 187: 1424-1432.
6. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 2004; 190: 1203-1211.
7. Hanage WP, Kaijalainen TH, Syrjanen RK et al. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun 2005; 73: 431-435.
8. Kronenberg A, Zucs P, Droz S, Muhlemann K. Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004. J Clin Microbiol 2006; 44: 2032-2038.
9. Sa-Leao R, Pinto F, Aguiar S et al. Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype. J Clin Microbiol 2011; 49: 1369-1375.
10. Sandgren A, Sjostrom K, Olsson-Liljequist B et al. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis 2004; 189: 785-796.
11. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J 2006; 25: 602-607.
12. Wroe PC, Lee GM, Finkelstein JA et al. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J 2012; 31: 249-254.
13. Yildirim I, Stevenson A, Hsu KK, Pelton SI. Evolving picture of invasive pneumococcal disease in Massachusetts children: a comparison of disease in 2007-2009 with earlier periods. Pediatr Infect Dis J 2012; 31: 1016-1021.
14. Dominguez A, Ciruela P, Garcia-Garcia JJ et al. Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study. Vaccine 2011; 29: 9020-9025.
15. Munoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008; 46: 174-182.
16. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1, 2013. http://www.eucast.org.
17. Selva L, del Amo E, Brotons P, Munoz-Almagro C. Rapid and easy identification of capsular serotypes of Streptococcus pneumoniae by use of fragment analysis by automated fluorescence-based capillary electrophoresis. J Clin Microbiol 2012; 50: 3451-3457.
18. Francisco AP, Vaz C, Monteiro PT, Melo-Cristino J, Ramirez M, Carrico JA. PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods. BMC Bioinformatics 2012; 13: 87.
19. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001; 125: 279-284.
20. Ardanuy C, Tubau F, Pallares R et al. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis 2009; 48: 57-64.
21. Hernandez-Bou S, Garcia-Garcia JJ, Gene A, Esteva C, del Amo E, Munoz-Almagro C. Pneumococcal carriage in children attending a hospital outpatient clinic in the era of pneumococcal conjugate vaccines in Barcelona. Diagn Microbiol Infect Dis 2012; 74: 258-262.
22. Aguiar SI, Brito MJ, Goncalo-Marques J, Melo-Cristino J, Ramirez M. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use. Vaccine 2010; 28: 5167-5173.
23. Esteva C, Selva L, de Sevilla MF, Garcia-Garcia JJ, Pallares R, Munoz-Almagro C. Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989-2008). Clin Microbiol Infect 2011; 17: 1441-1444.
24. Horacio AN, Diamantino-Miranda J, Aguiar SI, Ramirez M, Melo-Cristino J. Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections. Vaccine 2012; 30: 218-224.
25. Greenberg D, Givon-Lavi N, Newman N, Bar-Ziv J, Dagan R. Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric pneumonia as a means to estimate serotype disease potential. Pediatr Infect Dis J 2011; 30: 227-233.
26. Munoz-Almagro C, Esteva C, de Sevilla MF, Selva L, Gene A, Pallares R. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona. J Infect 2009; 59: 75-82.
27. Yildirim I, Hanage WP, Lipsitch M et al. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine 2010; 29: 283-288.
28. Rivera-Olivero IA, del Nogal B, Sisco MC, Bogaert D, Hermans PW, de Waard JH. Carriage and invasive isolates of Streptococcus pneumoniae in Caracas, Venezuela: the relative invasiveness of serotypes and vaccine coverage. Eur J Clin Microbiol Infect Dis 2011; 30: 1489-1495.
29. de Sevilla MF, Garcia-Garcia JJ, Esteva C et al. Clinical presentation of invasive pneumococcal disease in Spain in the era of heptavalent conjugate vaccine. Pediatr Infect Dis J 2012; 31: 124-128.
30. Trappetti C, van der Maten E, Amin Z et al. Site of isolation determines biofilm formation and virulence phenotypes of Streptococcus pneumoniae serotype 3 clinical isolates. Infect Immun 2013; 81: 505-513.
31. Valente C, Hinds J, Pinto F et al. Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine. PLoS One 2012; 7: e30235.
32. Nahm MH, Lin J, Finkelstein JA, Pelton SI. Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. J Infect Dis 2009; 199: 320-325.
33. Nunes S, Valente C, Sa-Leao R, de Lencastre H. Temporal trends and molecular epidemiology of recently described serotype 6C of Streptococcus pneumoniae. J Clin Microbiol 2009; 47: 472-474.